Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BCPC - BALCHEM CORP


169.2
-1.390   -0.822%

Share volume: 200,785
Last Updated: 03-11-2025
Chemicals/Chemicals And Allied Products: 0.01%

PREVIOUS CLOSE
CHG
CHG%

$170.59
-1.39
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
56%
Profitability 52%
Dept financing 12%
Liquidity 75%
Performance 67%
Company vs Stock growth
vs
Performance
5 Days
-3.69%
1 Month
6.29%
3 Months
-4.54%
6 Months
0.64%
1 Year
8.75%
2 Year
36.23%
Key data
Stock price
$169.20
P/E Ratio 
41.24
DAY RANGE
$168.05 - $171.18
EPS 
$3.97
52 WEEK RANGE
$137.69 - $186.03
52 WEEK CHANGE
$8.97
MARKET CAP 
5.299 B
YIELD 
0.53%
SHARES OUTSTANDING 
32.444 M
DIVIDEND
$0.3984
EX-DIVIDEND DATE
12-26-2023
NEXT EARNINGS DATE
N/A
BETA 
0.73
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$187,605
AVERAGE 30 VOLUME 
$161,109
Company detail
CEO: Theodore L. Harris
Region: US
Website: balchem.com
Employees: 1,340
IPO year: 1986
Issue type: Common Stock
Market: XNAS
Industry: Chemicals/Chemicals And Allied Products
Sector: Manufacturing

Balchem Corporation develops, manufactures, and markets specialty performance ingredients for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets. It operates through three segments: Human Nutrition, Animal Nutrition & Health, and Specialty Products. The company sells its products through sales force, independent distributors, and sales agents.

Recent news